March 25, 2015 — The U.S. Food and Drug Administration (FDA) has cleared Toshiba America Medical Systems new Infinix 4D CT system to enable computed tomography (CT) imaging directly in the cath lab. It integrates an Aquilion Prime CT system and Infinix Elite cardiovascular X-ray angiography system. The Infinix 4D CT previously received FDA clearance with the Infinix Elite cardiovascular X-ray system and Aquilion One Vision Edition CT system configuration.
The system offers an all-in-one interventional lab and CT solution to deliver real-time CT images during procedures instead of CT-like images. The system can significantly improve workflow with its SURE Guidance technology, which allows for automatic transition between modalities. In addition, it is capable of saving significant time by allowing clinicians to perform CT and interventional procedures within the same room and verify treatment success following procedures.
Clinically, the Infinix 4D CT maximizes workflow of oncology and cardiac procedures, as it provides interventionalists with CT images for the target anatomy. Clinicians now have the ability to adjust the procedure with real-time CT studies, instead of relying on CT images taken at an earlier time.
The Prime CT system comes in a 40-slice configuration, but can be upgraded in the field to an 80 or 160 slice system.
Toshiba showcased the system during the 2015 ACC meeting.
For more information: www.medical.toshiba.com
April 20, 2026 
